Medicare Enrolled
Dr. Vahe Akopian, MD
Neurology · Glendale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Akopian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Akopian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Akopian
Dr. Vahe Akopian is a neurology specialist in Glendale, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Akopian performed 2,625 Medicare services across 2,102 unique beneficiaries.
Between the years covered by Open Payments, Dr. Akopian received a total of $22,544 from 84 pharmaceutical and/or device companies across 993 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Akopian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 19% volume in CA
$22,544 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,625
Medicare services
Top 19% in CA for neurology
2,102
Unique beneficiaries
$137
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~202 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
515 | $100 | $227 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
325 | $145 | $440 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
250 | $98 | $248 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 227 | $213 | $584 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
206 | $72 | $214 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
162 | $108 | $294 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
162 | $177 | $615 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
152 | $126 | $363 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
128 | $404 | $1,018 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
126 | $248 | $592 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
116 | $54 | $389 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
109 | $31 | $90 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
66 | $41 | $329 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
44 | $144 | $324 |
| New patient office visit, complex (60-74 min) | 37 | $176 | $458 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,544
Total received (2018-2024)
Avg $3,221/year across 7 years
Top 14% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
993
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,739 (96.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$804 (3.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,730
2023
$3,601
2022
$3,765
2021
$3,872
2020
$2,674
2019
$1,994
2018
$1,907
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$357
Lundbeck LLC
$286
EMD Serono, Inc.
$278
Neurelis, Inc.
$259
SK Life Science, Inc.
$254
Lilly USA, LLC
$253
ABBVIE INC.
$250
UCB, Inc.
$228
Eisai Inc.
$200
Alexion Pharmaceuticals, Inc.
$198
PFIZER INC.
$194
Amneal Pharmaceuticals LLC
$182
Otsuka America Pharmaceutical, Inc.
$169
Neurocrine Biosciences, Inc.
$156
Novartis Pharmaceuticals Corporation
$151
Mallinckrodt Hospital Products Inc.
$141
Amgen Inc.
$138
MDD US Operations, LLC
$131
ACADIA Pharmaceuticals Inc
$115
ARGENX US, INC.
$111
Biogen, Inc.
$92
TG Therapeutics, Inc.
$82
Genentech USA, Inc.
$81
Imperative Care, Inc
$79
ANI Pharmaceuticals, Inc.
$70
Teva Pharmaceuticals USA, Inc.
$58
Boston Scientific Corporation
$36
JAZZ PHARMACEUTICALS INC.
$33
Sumitomo Pharma America, Inc.
$26
Merz Pharmaceuticals, LLC
$25
Kyowa Kirin, Inc.
$23
Alnylam Pharmaceuticals Inc.
$23
GE HEALTHCARE
$19
Aucta Pharmaceuticals, Inc.
$18
Vanda Pharmaceuticals Inc.
$14
Top 3 companies account for 19.5% of 2024 payments
All-time payments by company (2018-2024) ›
LivaNova USA, Inc.
$1,402
UCB, Inc.
$1,385
Teva Pharmaceuticals USA, Inc.
$1,332
EMD Serono, Inc.
$1,136
Celgene Corporation
$1,007
Biogen, Inc.
$1,004
Novartis Pharmaceuticals Corporation
$992
SK Life Science, Inc.
$853
Amgen Inc.
$764
ACADIA Pharmaceuticals Inc
$646
ABBVIE INC.
$614
Alexion Pharmaceuticals, Inc.
$601
AbbVie Inc.
$595
Lundbeck LLC
$571
Lilly USA, LLC
$540
AstraZeneca Pharmaceuticals LP
$407
PFIZER INC.
$406
Neurocrine Biosciences, Inc.
$393
MDD US Operations, LLC
$385
Horizon Therapeutics plc
$378
GENZYME CORPORATION
$374
Acorda Therapeutics, Inc
$362
Abbott Laboratories
$344
Amneal Pharmaceuticals LLC
$334
Janssen Pharmaceuticals, Inc
$316
Neurelis, Inc.
$302
Eisai Inc.
$296
Adamas Pharmaceuticals, Inc.
$265
Sunovion Pharmaceuticals Inc.
$251
Microtransponder, Inc.
$234
Otsuka America Pharmaceutical, Inc.
$218
Supernus Pharmaceuticals, Inc.
$215
Avanir Pharmaceuticals, Inc.
$198
Alnylam Pharmaceuticals Inc.
$185
Kyowa Kirin, Inc.
$176
Medtronic USA, Inc.
$164
ARGENX US, INC.
$156
Mallinckrodt Hospital Products Inc.
$141
TG THERAPEUTICS, INC.
$135
E.R. Squibb & Sons, L.L.C.
$134
Imperative Care, Inc
$131
Boston Scientific Corporation
$130
Allergan, Inc.
$127
UPSHER-SMITH LABORATORIES LLC
$122
Stryker Corporation
$121
Corium, LLC
$109
Biohaven Pharmaceutical Holding Company Ltd.
$97
Medtronic, Inc.
$94
TG Therapeutics, Inc.
$82
Genentech USA, Inc.
$81
Akcea Therapeutics, Inc.
$71
ANI Pharmaceuticals, Inc.
$70
Octapharma USA, Inc.
$68
Allergan Inc.
$67
US WorldMeds, LLC
$66
Sumitomo Pharma America, Inc.
$61
GE HEALTHCARE
$58
Catalyst Pharmaceuticals, Inc.
$57
Upsher-Smith Laboratories LLC
$57
Biohaven Pharmaceuticals, Inc.
$56
Takeda Pharmaceuticals U.S.A., Inc.
$48
MicroVention, Inc.
$47
ARBOR PHARMACEUTICALS, INC.
$44
BOSTON SCIENTIFIC CORPORATION
$41
Medtronic Vascular, Inc.
$36
JAZZ PHARMACEUTICALS INC.
$33
Vertiflex, Inc.
$32
Bayer HealthCare Pharmaceuticals Inc.
$31
PORTOLA PHARMACEUTICALS, INC.
$26
Merz Pharmaceuticals, LLC
$25
Mitsubishi Tanabe Pharma America, Inc.
$25
Harmony Biosciences LLC
$23
Arbor Pharmaceuticals, Inc.
$22
Cala Health, Inc.
$22
Aucta Pharmaceuticals, Inc.
$18
BANNER LIFE SCIENCES, LLC
$18
Assertio Therapeutics, Inc.
$18
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
Mylan Pharmaceuticals Inc.
$16
Vertical Pharmaceuticals, LLC
$15
Vanda Pharmaceuticals Inc.
$14
IDORSIA PHARMACEUTICALS US INC
$14
IMPEL PHARMACEUTICALS INC.
$12
Currax Pharmaceuticals LLC
$12
Top 3 companies account for 18.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · CALA KIQ · CONTRAVE · COPAXONE · CREXONT · Confirm Rx · DUOPA · ELIQUIS · EMGALITY · FRED · FYCOMPA · Fycompa · GAMMAGARD · GENERAL DBS · GENERAL PAIN MANAGEMENT · GOCOVRI · General - DBS · Glatiramer Acetate · Gocovri · Gralise · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LINQ II · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · Motpoly XR · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Rebif · Reveal LINQ · Rystiggo · S ICD · SOLIRIS · SPINRAZA · SURPASS EVOLVE · Soliris · Solitaire · Superion ISS · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TREVO · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WEB · Wakix · XADAGO · XARELTO · XCOPRI · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOOM 88-T LARGE DISTAL PLATFORM · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
535
Per 100K population
5.4
County median income
$87,760
Nearest hospital
GLENDALE ADVENTIST MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Akopian is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement in the top 14% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Akopian experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Akopian performed 515 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Akopian receive payments from pharmaceutical companies?
Yes. Dr. Akopian received a total of $22,544 from 84 companies across 993 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Akopian's costs compare to other neurologists in Glendale?
Dr. Akopian's average Medicare payment per service is $137. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Akopian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Glendale
Browse neurologists in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology